Leading the Way in Life Science Technologies

GEN Exclusives

More »
Insight & Intelligence™

Related to Reports Acknowledge FDA Progress but Cite Concerns on Agency Priorities, Management

  • Page 1 of 4 (72 items) 1 2 3 4  Last

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »